See more : Vection Technologies Limited (VR1.AX) Income Statement Analysis – Financial Results
Complete financial analysis of Nissan Medical Industries Ltd (NISA.TA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Nissan Medical Industries Ltd, a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- CleanGo Innovations Inc. (CLGOF) Income Statement Analysis – Financial Results
- Sydinvest Virksomhedsobligationer HY KL (SYIVOHYADKK.CO) Income Statement Analysis – Financial Results
- Petroreconcavo S.A. (RECV3.SA) Income Statement Analysis – Financial Results
- KR1 Plc (KROEF) Income Statement Analysis – Financial Results
- Chevalier International Holdings Limited (0025.HK) Income Statement Analysis – Financial Results
Nissan Medical Industries Ltd (NISA.TA)
Industry: Medical - Instruments & Supplies
Sector: Healthcare
Website: http://www.nissan-medical.co.il
About Nissan Medical Industries Ltd
Nissan Medical Industries Ltd, through its subsidiary, engages in the manufacturing and marketing of spunlace non-woven fabrics in the United States, Canada, Europe, and Israel. The company's products are used in reusable and consumable consumer products, medical products, automotive, infrastructure, hygienic, and other industries. It sells its products through its sales agents. Nissan Medical Industries Ltd was incorporated in 1984 and is based in Tel Aviv-Yafo, Israel.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 733.91M | 684.65M | 668.37M | 721.48M | 605.46M | 658.39M | 584.39M | 509.48M | 529.96M | 512.21M | 466.79M |
| Cost of Revenue | 598.14M | 601.37M | 523.95M | 540.03M | 509.90M | 538.83M | 494.94M | 402.43M | 375.88M | 390.20M | 358.28M |
| Gross Profit | 135.78M | 83.28M | 144.42M | 181.45M | 95.56M | 119.55M | 89.45M | 107.04M | 154.08M | 122.01M | 108.51M |
| Gross Profit Ratio | 18.50% | 12.16% | 21.61% | 25.15% | 15.78% | 18.16% | 15.31% | 21.01% | 29.07% | 23.82% | 23.25% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 10.33M | 9.38M | 8.58M | 9.54M | 9.03M | 9.60M | 9.33M | 9.50M | 9.32M | 7.77M | 7.48M |
| Selling & Marketing | 40.75M | 55.29M | 47.80M | 38.88M | 28.17M | 28.40M | 28.37M | 28.95M | 30.52M | 28.96M | 25.93M |
| SG&A | 51.09M | 64.67M | 56.38M | 48.42M | 37.21M | 38.00M | 37.70M | 38.44M | 39.84M | 36.72M | 33.41M |
| Other Expenses | 22.01M | 146.00K | -66.00K | 102.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 73.14M | 85.04M | 78.61M | 71.21M | 58.89M | 58.89M | 61.88M | 58.76M | 58.89M | 55.19M | 48.78M |
| Cost & Expenses | 671.28M | 686.41M | 602.56M | 611.25M | 568.79M | 597.72M | 556.82M | 461.20M | 434.78M | 445.39M | 407.05M |
| Interest Income | 179.00K | 11.00K | 0.00 | 85.00K | 14.00K | 0.00 | 92.00K | 19.00K | 6.00K | 13.00K | 35.00K |
| Interest Expense | 21.27M | 10.02M | 7.28M | 9.39M | 12.97M | 13.06M | 13.22M | 12.57M | 7.06M | 11.37M | 15.51M |
| Depreciation & Amortization | 31.14M | 28.65M | 25.60M | 27.42M | 28.69M | 26.18M | 26.08M | 24.79M | 17.92M | 16.81M | 15.99M |
| EBITDA | 80.23M | -8.35M | 91.40M | 137.76M | 65.44M | 86.80M | 53.65M | 73.07M | 113.10M | 85.73M | 75.73M |
| EBITDA Ratio | 10.93% | -1.21% | 14.65% | 20.25% | 11.85% | 13.44% | 8.81% | 15.23% | 22.21% | 16.74% | 16.98% |
| Operating Income | 62.69M | -23.58M | 65.18M | 108.13M | 34.72M | 61.66M | 26.95M | 47.57M | 94.58M | 69.00M | 59.04M |
| Operating Income Ratio | 8.54% | -3.44% | 9.75% | 14.99% | 5.73% | 9.37% | 4.61% | 9.34% | 17.85% | 13.47% | 12.65% |
| Total Other Income/Expenses | -34.87M | -23.44M | 5.20M | 1.88M | -3.81M | -11.10M | -14.88M | -8.37M | -6.90M | -35.49M | 20.00M |
| Income Before Tax | 27.82M | -47.02M | 70.45M | 110.01M | 30.91M | 50.56M | 12.07M | 39.20M | 87.68M | 33.51M | 79.03M |
| Income Before Tax Ratio | 3.79% | -6.87% | 10.54% | 15.25% | 5.11% | 7.68% | 2.07% | 7.69% | 16.55% | 6.54% | 16.93% |
| Income Tax Expense | 8.78M | 269.00K | 13.29M | 17.12M | 5.34M | 10.14M | -10.69M | 7.36M | 20.65M | 14.95M | 17.58M |
| Net Income | 5.65M | -36.05M | 36.01M | 56.85M | 15.71M | 25.10M | 12.71M | 17.91M | 37.13M | 603.00K | 46.70M |
| Net Income Ratio | 0.77% | -5.27% | 5.39% | 7.88% | 2.59% | 3.81% | 2.17% | 3.52% | 7.01% | 0.12% | 10.00% |
| EPS | 0.62 | -3.97 | 3.98 | 6.33 | 1.73 | 2.76 | 1.40 | 1.97 | 4.09 | 0.07 | 5.14 |
| EPS Diluted | 0.62 | -3.97 | 3.93 | 6.29 | 1.73 | 2.76 | 1.40 | 1.97 | 4.09 | 0.07 | 5.14 |
| Weighted Avg Shares Out | 9.08M | 9.08M | 9.08M | 9.08M | 9.08M | 9.08M | 9.08M | 9.08M | 9.08M | 9.08M | 9.08M |
| Weighted Avg Shares Out (Dil) | 9.08M | 9.08M | 9.08M | 9.08M | 9.08M | 9.08M | 9.08M | 9.08M | 9.08M | 9.08M | 9.08M |
Source: https://incomestatements.info
Category: Stock Reports